Nontherapeutic Human Experimentation
"Nontherapeutic Human Experimentation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Human experimentation that is not intended to benefit the subjects on whom it is performed. Phase I drug studies (CLINICAL TRIALS, PHASE I AS TOPIC) and research involving healthy volunteers are examples of nontherapeutic human experimentation.
|Nontherapeutic Human Experimentation
- Nontherapeutic Human Experimentation
- Nontherapeutic Research
- Research, Nontherapeutic
- Human Experimentation, Nontherapeutic
- Experimentation, Nontherapeutic Human
Below are MeSH descriptors whose meaning is more general than "Nontherapeutic Human Experimentation".
Below are MeSH descriptors whose meaning is more specific than "Nontherapeutic Human Experimentation".
This graph shows the total number of publications written about "Nontherapeutic Human Experimentation" by people in this website by year, and whether "Nontherapeutic Human Experimentation" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Nontherapeutic Human Experimentation" by people in Profiles.
Burdensome Research Procedures in Trials: Why Less Is More. J Natl Cancer Inst. 2017 04 01; 109(4).
The participation of children in nontherapeutic diabetes research in the US. Nat Clin Pract Endocrinol Metab. 2007 May; 3(5):378-9.
Pediatric research and the federal minimal risk standard. JAMA. 2006 Feb 15; 295(7):759; author reply 759-60.
Convening a 407 panel for research not otherwise approvable: "Precursors to diabetes in Japanese American youth" as a case study. Kennedy Inst Ethics J. 2004 Jun; 14(2):165-86.
Ethics and heroin prescription: no more fuzzy goals! Am J Bioeth. 2002; 2(2):52-3.
In defense of the Hopkins Lead Abatement Studies. J Law Med Ethics. 2002; 30(1):50-7.
Treating nondementia illnesses in patients with dementia. JAMA. 2000 Jun 28; 283(24):3230-5.
Quantitative analysis of ethical issues in phase I trials: a survey interview of 144 advanced cancer patients. IRB. 2000 May-Jun; 22(3):6-14.
Impact of therapeutic research on informed consent and the ethics of clinical trials: a medical oncology perspective. J Clin Oncol. 1999 May; 17(5):1601-17.
Study of cohort-specific consent and patient control in phase I cancer trials. J Clin Oncol. 1998 Jul; 16(7):2305-12.